Navigation Links
The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients

the IMF, added, "These findings may also have wider implications for cancer treatments because they challenge the traditional notion that patients should be treated with the highest dose of medicine they can tolerate. Now we have evidence that in some situations, less may be more when treating cancer."

REVLIMID from the Celgene Corporation is the newest of the group of medicines called novel therapies that have significantly improved the outlook for patients with myeloma. Preliminary analysis of the ECOG data shows patients taking REVLIMID plus low dose dexamethasone had a 96% survival rate after one year with a reduced risk of side effects. One year survival for those taking the higher dose of dexamethasone was 86%. The findings are expected to prompt review of the dexamethasone dose when paired with other medications used in myeloma such as THALOMID(R), and discussions are already underway to change dosing in other clinical trials using REVLIMID with dexamethasone.

"This is a very exciting finding for patients," said Michael Katz, who, as a 16-year myeloma survivor, is a vice president of the IMF and co-chair of ECOG's Patient Representatives Committee. "When ECOG's patient representatives proposed adding a lower dose 'dex' arm to this trial, we were just looking for a way to make the treatment more tolerable; we never expected that the outcome for patients would actually improve. We are grateful to all of the patients who participated and to ECOG Group chair, Dr. Robert Comis and Myeloma Committee chair, Dr. Vincent Rajkumar, for supporting the notion of testing lower doses and making this trial happen."

Mr. Katz continued: "This result sends an important signal to physicians that maximum tolerated dose is not always the right answer when treating patients with cancers like myeloma that are incurable, but highly treatable."

Myeloma, also called multiple myeloma, is a cancer of the bone marrow that affects production of red cells, white
'"/>




Page: 1 2 3

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
Post Your Comments:
(Date:7/28/2014)... , July 28, 2014 Reportbuyer.com has ... Global Bone Densitometers Market 2014-2018 ... bone densitometry scan is a special type of X-ray ... bone. It is used primarily to detect osteopenia or ... and the risk of fractures is high. The purpose ...
(Date:7/28/2014)... July 28, 2014 /PRNewswire-iReach/ -- June 28 th , 2014 ... has developed the AMAS cancer test, is making its AACC ... date, the test, which is a serum-based in vitro immunoassay, ... as a significant tool in the fight against cancer recurrence. ... With an estimated 17 million cancer survivors in the US ...
(Date:7/28/2014)...  Surgical Theater, LLC announced today the addition ... Board. New members include Ori J. Braun ... and New Technologies for Given Imaging Ltd., and ... President and General Manager of Philips Healthcare,s Computer ... technology to brain surgery and has developed software-based ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5
... Companies to Lead Public and Investor Relations Efforts -- BEIJING, Sept. 8 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...
... FALLS, Idaho, Sept. 8 International Isotopes Inc. (OTC ... an agreement with URENCO USA to provide assistance to ... State of New Mexico permitting processes. INIS ... Commission (NRC) in December 2009 for the construction of ...
Cached Medicine Technology:Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 2Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 3Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 4Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 5Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 6Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 7Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 8International Isotopes Inc. Announces Completion of a Licensing and Permitting Assistance Agreement with URENCO USA 2International Isotopes Inc. Announces Completion of a Licensing and Permitting Assistance Agreement with URENCO USA 3
(Date:7/28/2014)... 28, 2014 Ticket Down is ... tickets in Dallas, TX at the Cotton Bowl. The ... the USA and it is an eight team tourney. ... world including teams from La Liga, Serie A, English Premier ... battle it out on the pitch include: Manchester United, ...
(Date:7/28/2014)... York, NY (PRWEB) July 28, 2014 ... the body and it’s considered to be conditionally essential ... stress and is an advanced recovery & Immune System ... all the glutamine your body produces, supplementing with additional ... removal of waste products in the body, digestion and ...
(Date:7/28/2014)... Salamon HealthDay Reporter ... children who are at risk of contracting meningitis because ... infection, according to updated recommendations from the largest pediatrician ... vaccinations for the potentially deadly infection should continue for ... says. In its first statement on meningococcal vaccines ...
(Date:7/28/2014)... July 28, 2014 (HealthDay News) -- Endurance runners are ... an undetected heart condition, according to a new study. ... participating in events in warm climates are actually 10 ... stroke. Yet, the less common sudden death of a ... problems, such as an irregular heartbeat, often gets a ...
(Date:7/28/2014)... SIMpalm helped its client to launch Audio ... iTunes for download . Experience a new way to ... to listen and cook along with expert real-time audio instruction. ... the ingredients and equipment, press play, and follow the step-by-step ... of time, just relax and cook along with us. For ...
Breaking Medicine News(10 mins):Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4
... follow them to the base, study found , FRIDAY, May ... currently in the service appear to be happy with the ... observation stems from a study conducted in 2008 by researchers ... 700 U.S. Army soldiers stationed at Fort Riley, in Kansas, ...
... ... for Improvement in Various Stages of the RN Employment Lifecycle: Engagement, Retention and ... Charlotte, ... a webinar titled “Creating a High-Performing RN Workforce.” The free hour-long webinar will ...
... new investigational drug, discovered by researchers at Cardiff University, ... by Hepatitis C virus. , Approximately 170 million people ... to liver cancer, cirrhosis and death. It is the ... current treatment involves two drugs ribavirin and interferon, ...
... (PHILADELPHIA) Bladder cancer often becomes aggressive and spreads in ... Center at Jefferson have identified a protein they believe is ... "We have found that IGF-IR is a critical ... this could offer us a novel molecular target to treat ...
... In 2008, an estimated 55,000 hospitalizations were prevented in ... -- Vaccination against rotavirus greatly reduces the risk of ... , Rotavirus, a leading cause of severe diarrhea ... more than half a million deaths worldwide each year. ...
... had no effect, researchers found , FRIDAY, May 14 (HealthDay News) ... your distance from the friendly and helpful saleswoman. , A series ... found both men and women were more likely to take financial ... new research shows. , The same contact with a man did ...
Cached Medicine News:Health News:Most Military Couples Satisfied With Their Relationships 2Health News:Morehead Presents Webinar on “Creating a High-Performing RN Workforce” 2Health News:Clue to switch of bladder cancer from locally contained to invasive found by Jefferson scientists 2Health News:Rotavirus Vaccine Helps Kids Avoid Severe Gastro Illness 2Health News:A Woman's Touch Encourages Financial Risk-Taking 2Health News:A Woman's Touch Encourages Financial Risk-Taking 3
... external catheter is specially designed for the special ... a forward-placement adhesive band will work for men ... also be preferred when a longer sheath is ... a different adhesive location on their skin. The ...
... WideBand is the new standard for ... adhesive is built into nearly the entire ... area than is found in the self-adhering ... Corporation has patented this advanced manufacturing process, ...
... The controlled-release nitrofurazone Foley catheter, RELEASE-NF, is ... is the first and only Foley that ... placed in a patient, the RELEASE-NF catheter ... surrounding aqueous environment of the urethral tract. ...
... Used for stone manipulation ... urinary tract. Enhanced wire ... dilation in the ureter. ... easy, ergonomic one-handed operation. ...
Medicine Products: